Xiaotao Qu

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial

Padmanee Sharma, Margitta Retz, Arlene O. Siefker‐Radtke et al. · The Lancet Oncology · 2017 · 1.7K citations

Medicine, Oncology, Urology +12

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

David A. Palma, Robert Olson, Stephen Harrow et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

Ganna Chornokur, Hui‐Yi Lin, Jonathan P. Tyrer et al. · PLoS ONE · 2015 · 906 citations · Full text

Medicine, Genetics, Oncology +17

12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

Jane L. Messina, David Fenstermacher, Steven A. Eschrich et al. · Scientific Reports · 2012 · 421 citations · Full text

Medicine, Immunology, Oncology +17

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

Paul D.P. Pharoah, Ya-Yu Tsai, Susan J. Ramus et al. · Nature Genetics · 2013 · 361 citations · Full text

Life Sciences, Genetics, Oncology +14